Location History:
- Åkersberga, SE (2017)
- Umeå, SE (2019 - 2020)
Company Filing History:
Years Active: 2017-2020
Title: Ronnie Per Arne Berntsson: Innovator in Botulinum Neurotoxin Research
Introduction
Ronnie Per Arne Berntsson is a notable inventor based in Umeå, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of engineered botulinum neurotoxins. With a total of three patents to his name, Berntsson's work has implications for both medical and pharmaceutical applications.
Latest Patents
Berntsson's latest patents focus on engineered botulinum neurotoxin (BoNT) polypeptides. These polypeptides feature a modified receptor binding domain of serotype B, incorporating various substitution mutations. Specific mutations include V1118M, Y1183M, E1191M, E1191I, E1191Q, E1191T, S1199Y, S1199F, S1199L, and S1201V. The patents also disclose combinations of these mutations, such as E1191M and S1199L, as well as pharmaceutical compositions and methods for their use.
Career Highlights
Throughout his career, Berntsson has worked with prestigious institutions, including Harvard College and Harvard Corporation. His research has advanced the understanding of botulinum neurotoxins and their potential applications in medicine.
Collaborations
Berntsson has collaborated with notable researchers, including Min Dong and Lisheng Peng. These partnerships have contributed to the depth and breadth of his research in the field.
Conclusion
Ronnie Per Arne Berntsson is a distinguished inventor whose work in engineered botulinum neurotoxins has the potential to impact various medical fields. His innovative research continues to pave the way for advancements in biotechnology.